The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders. Basic net loss per share is computed by dividing net loss for the period by the weighted-average number of common shares outstanding during the period, which excludes Sponsor Vesting Shares which are legally outstanding, but subject to return to the Company. Diluted net loss per share is computed by dividing net loss for the period by the weighted-average common shares outstanding during the period, plus the dilutive effect of the stock options and RSU awards, as applicable pursuant to the treasury stock method. The following table sets forth the computation of basic and diluted net loss per share:


(In thousands, except for share and per share amounts)	Three Months Ended March 31,
		2026		2025
Numerator:
Net loss attributable to common stockholders—Basic		$	(17,650)	$	(26,441)
Net loss attributable to common stockholders—Diluted		$	(17,650)	$	(26,441)
Denominator:
Weighted-average common shares outstanding—Basic (1)		5,377,854		4,895,078


Weighted-average common shares outstanding—Diluted (1)		5,377,854		4,895,078

Net loss per share—Basic		$	(3.28)	$	(5.40)
Net loss per share—Diluted		$	(3.28)	$	(5.40)

(1)Excludes weighted-average Sponsor Vesting Shares subject to return of 50,000 and 100,000 shares for each of the three months ended March 31, 2026 and 2025, respectively.

Diluted net loss per share reflects the potential dilution of securities that could dilute share in the earnings of an entity. The following potentially dilutive securities for common stock were outstanding and excluded from diluted net loss per share as they are subject to performance or market conditions that were not achieved as follows:


	Three Months Ended March 31,
		2026	2025
Options to purchase common stock		35,274	35,274
Performance-based stock awards		33,750	70,808
Earnout shares		833,333	833,333
Sponsor Vesting Shares		50,000	100,000

The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been antidilutive:


	Three Months Ended March 31,
		2026	2025
Options to purchase common stock		192,955	95,218
Warrants to purchase common stock		1,182,554	1,182,554


RSU awards		307,807	435,970
Convertible notes (if converted)		393,680	—